PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Front-Line Covid-19 Critical Care Alliance, Madison, WI.\', \'Memphis VA Medical Center-University of Tennessee Health Science Center, Pulmonary, Critical Care, and Research Services, Memphis, TN.\', \'University of Texas Health Science Center, Critical Care Service, Houston, TX.\', \'Department of Medicine, Hackensack School of Medicine, Seton Hall, NJ; and.\', \'Eastern Virginia Medical School, Division of Pulmonary and Critical Care, Norfolk, VA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/MJT.0000000000001377
?:hasPublicationType
?:journal
  • American journal of therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 34375047
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.399
?:rankingScore_hIndex
  • 54
?:title
  • Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all